Anna Gluskin
Directeur/Membre du Conseil chez EASTGATE BIOTECH CORP.
Postes actifs de Anna Gluskin
Sociétés | Poste | Début | Fin |
---|---|---|---|
EASTGATE BIOTECH CORP. | Directeur/Membre du Conseil | - | - |
Directeur Général | 22/05/2012 | - | |
Président | 22/05/2012 | - | |
Eastgate Pharmaceuticals, Inc.
Eastgate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eastgate Pharmaceuticals, Inc. operates as a pharmaceutical research and product company. The company is headquartered in North York, Canada. | Directeur Général | 01/03/2011 | - |
Historique de carrière de Anna Gluskin
Anciens postes connus de Anna Gluskin
Sociétés | Poste | Début | Fin |
---|---|---|---|
NUGENEREX IMMUNO-ONCOLOGY, INC. | Directeur/Membre du Conseil | 14/01/2011 | 14/01/2011 |
Generex Pharmaceuticals, Inc.
Generex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Generex Biotechnology Corp., Generex Pharmaceuticals, Inc. provides pharmaceutical products. The company is based in Toronto, Canada. | Directeur/Membre du Conseil | 14/01/2011 | 14/01/2011 |
PROTECT PHARMACEUTICAL CORPORATION | Directeur/Membre du Conseil | 02/07/2010 | 01/09/2010 |
GENEREX BIOTECHNOLOGY CORPORATION | Directeur Général | 01/11/1995 | 01/09/2010 |
Fondateur | 01/11/1995 | 01/09/2010 | |
President | 01/11/1995 | 01/09/2010 | |
Interlock Consolidated Enterprises, Inc. | Directeur/Membre du Conseil | - | - |
Formation de Anna Gluskin
Moscow State University Lomonosov | Graduate Degree |
University of Toronto | Graduate Degree |
Statistiques
Internationale
Canada | 6 |
Etats-Unis | 4 |
Russie | 2 |
Opérationnelle
Director/Board Member | 5 |
Chief Executive Officer | 3 |
Graduate Degree | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 3 |
Transportation | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
PROTECT PHARMACEUTICAL CORPORATION | Transportation |
EASTGATE BIOTECH CORP. | Health Technology |
Entreprise privées | 5 |
---|---|
Generex Pharmaceuticals, Inc.
Generex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Generex Biotechnology Corp., Generex Pharmaceuticals, Inc. provides pharmaceutical products. The company is based in Toronto, Canada. | Health Technology |
NuGenerex Immuno-Oncology, Inc.
NuGenerex Immuno-Oncology, Inc. BiotechnologyHealth Technology NuGenerex Immuno-Oncology, Inc. is an oncology company focuses on the modulation of the immune system to treat cancer. It develops immunotherapeutic products and vaccines based on proprietary, patented platform technology, Ii-Key. The Ii-Key is a peptide derived from the major histocompatibility complex (MHC) class II associated invariant chain that regulates the formation, trafficking, and antigen-presenting functions of MHC class II complexes, essential for the activation of T cells in the immune response. The company was founded on October 8, 1993 and is headquartered in Miramar, FL. | Health Technology |
Eastgate Pharmaceuticals, Inc.
Eastgate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eastgate Pharmaceuticals, Inc. operates as a pharmaceutical research and product company. The company is headquartered in North York, Canada. | Health Technology |
Interlock Consolidated Enterprises, Inc. | |
Generex Biotechnology Corp.
Generex Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Generex Biotechnology Corp. is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. It builds new kind of healthcare company, which provides support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. The company was founded by Rose C. Perri on September 4, 1997 and is headquartered in Miramar, FL. | Health Technology |
- Bourse
- Insiders
- Anna Gluskin
- Expérience